Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

Clinical trial NCT03955783 · COMPLETED

Trial details

NCT number: NCT03955783
Sponsor: Sanjay Mohan
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma Acute Myeloid Leukemia Non-Hodgkin's Lymphoma

Start date: 2019-06-21
Primary completion: 2024-09-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.